PVLA
Palvella Therapeutics, Inc. Common Stock
PVLA
PVLA
115 hedge funds and large institutions have $179M invested in Palvella Therapeutics, Inc. Common Stock in 2018 Q2 according to their latest regulatory filings, with 20 funds opening new positions, 45 increasing their positions, 30 reducing their positions, and 20 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
115
Holders Change
–
Holders Change %
0%
% of All Funds
2.64%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.05%
New
20
Increased
45
Reduced
30
Closed
20
Calls
$1K
Puts
$486K
Net Calls
-$485K
Net Calls Change
+$244K
Top Buyers
| 1 |
BI
BVF Inc
San Francisco,
California
|
$27.1M |
| 2 |
BlackRock
New York
|
$13.6M |
| 3 |
PM
Prosight Management
Dallas,
Texas
|
$6.9M |
| 4 |
Acadian Asset Management
Boston,
Massachusetts
|
$10.8M |
| 5 |
American Century Companies
Kansas City,
Missouri
|
$2.37M |
Top Sellers
| 1 |
O
OrbiMed
New York
|
$15.9M |
| 2 |
Morgan Stanley
New York
|
$641K |
| 3 |
Millennium Management
New York
|
$5.48M |
| 4 |
EI
EAM Investors
Solana Beach,
California
|
$0 |
| 5 |
AL
AJO LP
Philadelphia,
Pennsylvania
|
$0 |
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
ECM
126
Element Capital Management
New York
| – | -$331K | -606 | Closed |
|
|
EMG
127
Ellington Management Group
Old Greenwich,
Connecticut
| – | -$304K | -558 | Closed |
|
|
GAM
128
Gotham Asset Management
New York
| – | -$250K | -458 | Closed |
|
|
AAC
129
Acorn Advisory Capital
New York
| – | -$188K | -344 | Closed |
|
|
ARTA
130
A.R.T. Advisors
New York
| – | -$103K | -189 | Closed |
|
|
CG
131
Caprock Group
Boise,
Idaho
| – | -$86K | -157 | Closed |
|
132
William Blair & Company
Chicago,
Illinois
| – | -$75K | -138 | Closed |
|
|
TRCT
133
Tower Research Capital (TRC)
New York
| – | -$1K | -2 | Closed |
|
|
APA
134
American Portfolios Advisors
Holbrook,
New York
| – | -$1.02K | -2 | Closed |
|